A detailed history of Glen Eagle Advisors, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 110 shares of WST stock, worth $35,576. This represents 0.01% of its overall portfolio holdings.

Number of Shares
110
Holding current value
$35,576
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 03, 2024

BUY
$338.27 - $413.0 $37,209 - $45,430
110 New
110 $43.5 Million
Q3 2020

Aug 13, 2024

BUY
$224.99 - $288.02 $24,748 - $31,682
110 New
110 $30.2 Million
Q4 2019

Aug 13, 2024

SELL
$137.6 - $151.21 $6,604 - $7,258
-48 Closed
0 $0
Q3 2019

Aug 13, 2024

SELL
$121.41 - $150.02 $7,527 - $9,301
-62 Reduced 56.36%
48 $6.81 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.9B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.